bazedoxifene: Clinical Trials

8 trials of bazedoxifene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 1 withdrawn. 8 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Active not recruiting 2, Withdrawn 1
Phase 11Completed 1

Follow bazedoxifene: new trials by email Literature Review of bazedoxifene trials Research Report on bazedoxifene

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans
Placebo, conjugated estrogens/bazedoxifene (CE/BZA) - Menopause, Prediabetes
Phase 2WithdrawnVA Office of Research and Development2024-04-082024-05-10
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Bazedoxifene and Conjugated Estrogens - Risk Reduction, Breast Cancer
Phase 2Active not recruitingUniversity of Kansas Medical Center1202021-12-142026-10-27
Advancing Postmenopausal Preventive Therapy
Oral bazedoxifene 20 mg / conjugated estrogens 0.45 mg, Placebo - Atherosclerosis, Cognitive Decline
Phase 2Active not recruitingUniversity of Southern California3852021-04-132024-12-05
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
Bazedoxifene Acetate - Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Phase 2CompletedRiley Bove, MD632019-09-102025-06-08
The PROMISE Study: Duavee in Women With DCIS
Conjugated Estrogens/Bazedoxifene, Laboratory Biomarker Analysis, Pharmacological Study - Ductal Breast Carcinoma In Situ, Postmenopausal
Phase 2CompletedNorthwestern University1422017-01-012025-01-28
Pilot Study of the Effect of DuaveeĀ® on Benign Breast Tissue Proliferation
Duavee - Breast Cancer
Phase 2CompletedUniversity of Kansas Medical Center282016-05-012022-03-09
A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer
Palbociclib, Bazedoxifene - Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer
Phase 1 / Phase 2CompletedDana-Farber Cancer Institute362015-07-092022-10-24
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Bazedoxifene, Placebo - Postmenopausal Osteoporosis
Phase 2CompletedWyeth is now a wholly owned subsidiary of Pfizer3752003-08-012007-12-20

Conditions studied

Breast Neoplasms (3)  ·  Hot Flashes (2)  ·  Atherosclerosis (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes Mellitus (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Obesity (1)  ·  Osteoporosis, Postmenopausal (1)  ·  Prediabetic State (1)  ·  Risk Reduction Behavior (1)

Sponsors

University of Kansas Medical Center (2)  ·  Dana-Farber Cancer Institute (1)  ·  Northwestern University (1)  ·  Riley Bove, MD (1)  ·  University of Southern California (1)  ·  VA Office of Research and Development (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

United States (7)

Top investigators

Carol Fabian, MD (1)  ·  Carol J Fabian, MD (1)  ·  Dragana Lovre, MD (1)  ·  Howard N. Hodis, MD (1)  ·  Riley M Bove, MD MMSc (1)  ·  Rinath Jelsohn, MD (1)  ·  Swati Kulkarni, MD (1)

Results publications

PMID 20839291, PMID 31420361, PMID 36215125, PMID 37715710, PMID 37739167, PMID 39293780

NIH funding

1IK2CX002225-01A1 (1), P30CA060553 (1), R01AG058691 (1), R01CA249437 (1)